234 related articles for article (PubMed ID: 9442490)
21. [Streptococcal pharyngitis].
Romero J; Betriu C
Enferm Infecc Microbiol Clin; 1995 Dec; 13(10):611-27. PubMed ID: 8808478
[No Abstract] [Full Text] [Related]
22. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance.
Cornaglia G; Ligozzi M; Mazzariol A; Valentini M; Orefici G; Fontana R
Emerg Infect Dis; 1996; 2(4):339-42. PubMed ID: 9011381
[TBL] [Abstract][Full Text] [Related]
23. [Streptococcus pyogenes and resistance to macrolides: experience at Monza].
Minerva Pediatr; 1998; 50(1-2):XII-XIII. PubMed ID: 9658791
[No Abstract] [Full Text] [Related]
24. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile.
Palavecino EL; Riedel I; Berrios X; Bajaksouzian S; Johnson D; Kaplan E; Jacobs MR
Antimicrob Agents Chemother; 2001 Jan; 45(1):339-41. PubMed ID: 11120993
[TBL] [Abstract][Full Text] [Related]
25. Survey of emm gene sequences from pharyngeal Streptococcus pyogenes isolates collected in Spain and their relationship with erythromycin susceptibility.
Albertí S; García-Rey C; Domínguez MA; Aguilar L; Cercenado E; Gobernado M; García-Perea A;
J Clin Microbiol; 2003 Jun; 41(6):2385-90. PubMed ID: 12791853
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
[TBL] [Abstract][Full Text] [Related]
27. Decline in macrolide-resistant Streptococcus pyogenes isolates from French children.
d'Humières C; Cohen R; Levy C; Bidet P; Thollot F; Wollner A; Bingen E
Int J Med Microbiol; 2012 Dec; 302(7-8):300-3. PubMed ID: 23103047
[TBL] [Abstract][Full Text] [Related]
28. SmaI macrorestriction analysis of Italian isolates of erythromycin-resistant Streptococcus pyogenes and correlations with macrolide-resistance phenotypes.
Ripa S; Zampaloni C; Vitali LA; Giovanetti E; Montanari MP; Prenna M; Varaldo PE
Microb Drug Resist; 2001; 7(1):65-71. PubMed ID: 11310805
[TBL] [Abstract][Full Text] [Related]
29. High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children.
Syrogiannopoulos GA; Grivea IN; Fitoussi F; Doit C; Katopodis GD; Bingen E; Beratis NG
Pediatr Infect Dis J; 2001 Sep; 20(9):863-8. PubMed ID: 11734765
[TBL] [Abstract][Full Text] [Related]
30. Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan.
Hsueh PR; Teng LJ; Lee LN; Yang PC; Ho SW; Lue HC; Luh KT
Microb Drug Resist; 2002; 8(1):27-33. PubMed ID: 12002646
[TBL] [Abstract][Full Text] [Related]
31. Macrolide-resistance genes in clinical isolates of Streptococcus pyogenes.
Cascone C; Santagati M; Noviello S; Iannelli F; Esposito S; Pozzi G; Stefani S
Microb Drug Resist; 2002; 8(2):129-32. PubMed ID: 12118517
[TBL] [Abstract][Full Text] [Related]
32. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance.
Cornaglia G; Ligozzi M; Mazzariol A; Masala L; Lo Cascio G; Orefici G; Fontana R
Clin Infect Dis; 1998 Aug; 27 Suppl 1():S87-92. PubMed ID: 9710676
[TBL] [Abstract][Full Text] [Related]
33. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh.
Martin JM; Green M; Barbadora KA; Wald ER
N Engl J Med; 2002 Apr; 346(16):1200-6. PubMed ID: 11961148
[TBL] [Abstract][Full Text] [Related]
34. Streptococcus pyogenes isolated in Portugal: macrolide resistance phenotypes and correlation with T types. Portuguese Surveillance Group for the Study of Respiratory Pathogens.
Melo-Cristino J; Fernandes ML
Microb Drug Resist; 1999; 5(3):219-25. PubMed ID: 10566873
[TBL] [Abstract][Full Text] [Related]
35. The emergence of erythromycin-resistant Streptococcus pyogenes in Seoul, Korea.
Cha S; Lee H; Lee K; Hwang K; Bae S; Lee Y
J Infect Chemother; 2001 Jun; 7(2):81-6. PubMed ID: 11455497
[TBL] [Abstract][Full Text] [Related]
36. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group.
Varaldo PE; Debbia EA; Nicoletti G; Pavesio D; Ripa S; Schito GC; Tempera G
Clin Infect Dis; 1999 Oct; 29(4):869-73. PubMed ID: 10589905
[TBL] [Abstract][Full Text] [Related]
37. [Current Streptococcus pyogenes sensitivity responsible for acute tonsillopharyngitis in France].
Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
Presse Med; 2004 Jun; 33(11):703-6. PubMed ID: 15257225
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania.
Cocuzza C; Blandino G; Mattina R; Nicoletti F; Nicoletti G
Microb Drug Resist; 1997; 3(4):379-84. PubMed ID: 9442491
[TBL] [Abstract][Full Text] [Related]
39. Decline in erythromycin resistance in group A Streptococci from acute pharyngitis due to changes in the emm Genotypes rather than restriction of antibiotic use.
Koh E; Kim S
Korean J Lab Med; 2010 Oct; 30(5):485-90. PubMed ID: 20890080
[TBL] [Abstract][Full Text] [Related]
40. Utilisation of macrolides and the development of Streptococcus pyogenes resistance to erythromycin.
Urbánek K; Kolár M; Cekanová L
Pharm World Sci; 2005 Apr; 27(2):104-7. PubMed ID: 15999920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
